e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
COPD management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The subclinical atherosclerosis and its association to clinical features of stable COPD
O. Salman Sever, I. Conkbayir, M. Yuce Ege, S. Akcali, H. Firat, T. Kaplan, S. Ardic (Ankara, Turkey)
Source:
Annual Congress 2011 - COPD management
Session:
COPD management
Session type:
Thematic Poster Session
Number:
546
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Salman Sever, I. Conkbayir, M. Yuce Ege, S. Akcali, H. Firat, T. Kaplan, S. Ardic (Ankara, Turkey). The subclinical atherosclerosis and its association to clinical features of stable COPD. Eur Respir J 2011; 38: Suppl. 55, 546
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Structural and biochemical characteristics of subclinical atherosclerosis in COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
The relationship between bronchial inflammation and markers of disease progression in COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 179s
Year: 2003
Cardiovascular risk, subclinical atherosclerosis and markers of systemic inflammation in patients with COPD and frequent exacerbator phenotype
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
The link between systemic inflammation and pulmonary hypertension in patients with stable COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 53s
Year: 2005
Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations.
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018
The relationship of comorbidities with clinical and phsyiological parameters in COPD
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012
Relationship of systemic inflammation and autoimmunity to clinically relevant outcomes in COPD
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Evaluation of metabolic profile in patients with chronic obstructive pulmonary disease and correlation between the metabolic parameters and the severity of disease
Source: Eur Respir J 2006; 28: Suppl. 50, 625s
Year: 2006
The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma
Source: Eur Respir J 2003; 22: 470-477
Year: 2003
Relationship between circulating thrombomodulin levels and latent progression of atherosclerosis in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008
A new paradigm for classification of disease severity and progression of COPD
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012
The association between COPD and cardiovascular disorders
Source: International Congress 2017 – COPD and comorbid cardiovascular diseases
Year: 2017
The relationship between comorbidities and systemic inflammation in patients with COPD
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011
Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020
Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients
Source: Annual Congress 2011 - COPD: human studies
Year: 2011
The prognostic importance of the protease-antiprotease imbalance in development of chronic obstructive pulmonary disease comorbid with chronic pancreatitis
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort
Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Year: 2007
Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 335s
Year: 2001
Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008
Prevalence and clinical relevance of comorbidities in IPF
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept